ABEMACICLIB , RO7197597
GIM31-Neo-AGILE
Phase 2 small_molecule active
Quick answer
ABEMACICLIB , RO7197597 for ER-positive, HER2-negative Early breast cancer is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- ER-positive, HER2-negative Early breast cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active